Role of the Plasminogen Activator-Plasmin System in Angiogenesis
-
Published:2003
Issue:
Volume:
Page:269-290
-
ISSN:
-
Container-title:Plasminogen: Structure, Activation, and Regulation
-
language:
-
Short-container-title:
Author:
Pepper Michael S.
Reference144 articles.
1. Andreasen, P.A., Egelund, R., and Petersen, H.H. (2000). The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57, 25–40. 2. Asahara, T., Bauters, C., Zheng, L.P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J.F., and Isner, J.M. (1995). Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92(Suppl. II), II-365–II-371. 3. Bacharach, E., Itin, A., and Keshet, E. (1998). Apposition-dependent induction of plasminogen activator inhibitor type-1 expression: A mechanism for balancing pericellular proteolysis during angiogenesis. Blood 92, 939–945. 4. Bajou, K., Masson, V., Gerard, R.D., Schmitt, P.M., Albert, V., Praus, M., Lund, L.R., Frandsen, T.L., Brunner, N., Dano, K., Fusenig, N.E., Weidle, U., Carmeliet, G., Loskutoff, D., Collen, D., Carmeliet, P., Foidart, J.M., and Noël, A. (2001).The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies. J. Cell Biol. 152, 777–784. 5. Bajou, K., Noel, A., Gerard, R.D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N.E., Carmeliet, P., Collen, D., and Foidart, J.M. (1998). Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med. 4, 923–928.
|
|